Sort
15,440 grants matching “organoids”
Radiation-induced Salivary Gland Vascular Injury: Mechanisms and Interventions
$471,502Mukund Seshadri · Roswell Park Cancer Institute Corp · R56 · FY2022 · DE
Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)
$471,484Andrei G Fedorov · Georgia Institute Of Technology · R01 · FY2025 · GM
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
$471,200Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Role of Hypoxia-inducible factor-2a in L-cell nutrient sensing and metabolic homeostasis
$471,136Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers
$471,073Benjamin Elison Gewurz · Wistar Institute · P01 · FY2023 · CA
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
$471,066Xuefeng Liu · Ohio State University · R01 · FY2022 · CA
Functional consequences of mutations in spliceosomal small nuclear RNAs
$471,003Richard A Padgett · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · GM
Role of CHAMP1, a neurodevelopmental disorder high risk gene, in human brain development and function
$470,895Stefano Berto · Medical University Of South Carolina · R01 · FY2025 · HD
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
$470,750Timothy Joel Cherry · Seattle Children'S Hospital · R01 · FY2019 · EY
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
$470,750Timothy Joel Cherry · Seattle Children'S Hospital · R01 · FY2020 · EY
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
$470,750Timothy Joel Cherry · Seattle Children'S Hospital · R01 · FY2023 · EY
Trophoblast development and placental susceptibility to cytomegalovirus infection
$470,637Craig John Bierle · University Of Minnesota · R01 · FY2024 · HD
Role of TGFβ/BMP Antagonism in Regeneration of the Alveolar Epithelium After Lung Injury
$470,579Rachel Lynne Zemans · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Flexible bioelectronics platform converging capillary-like delivery network and sensing feedback network for improving cardiac tissue engineering
$470,537Jun Yao · University Of Massachusetts Amherst · R33 · FY2025 · HL
RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
$470,471Wei Yang · Cedars-Sinai Medical Center · R01 · FY2022 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$470,418William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Disease model design and evaluation
$470,392Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Personalized cancer models to discover and develop new therapeutic targets.
$470,312Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$470,310Xiaoqi Liu · University Of Kentucky · R01 · FY2024 · CA
Targeting CEBPA To Restore Epithelial-Mesenchymal Homeostasis In Lung Fibrosis
$470,306Qi Tan · University Of Minnesota · R01 · FY2023 · HL
Role of STING in Cholestatic Liver Injury
$470,085Shannon Stroud Glaser · Texas A&M University Health Science Ctr · R01 · FY2025 · DK
Elucidating the Role of Tryptophan Hydroxylase 1 in Neuroendocrine Prostate Cancer
$470,027Boyang Wu · Washington State University · R01 · FY2025 · CA
Roles for Lrig1 in Intestinal Neoplasia
$470,011Robert J Coffey · Vanderbilt University Medical Center · R01 · FY2016 · CA
A non-canonical role for EZH2 in rRNA methtlation
$469,932Qi Cao · Northwestern University At Chicago · R01 · FY2021 · CA
Novel Approaches for Improving Inflammation Resolution Following Chronic Exposure to Air Pollutants
$469,879Srinivasa Reddy · University Of California Los Angeles · R01 · FY2024 · ES